Patient story
Sunita C., 66
Cancer of the rectum and anal canal, stage 2 · Dadar · With us: Nov 2025 → Feb 2026, through her oncology treatment
Haemoglobin (g/dL)
23 Nov 2025 → 15 Feb 2026
White cells 2,800 → 6,500
What changed
- Mouth ulcers cleared
- Taste and appetite came back
- Fever and gas settled
- Weakness reduced
- No pain while passing stool
Alongside: Her cancer treatment was led by her oncology team: chemotherapy tablets, 28 radiation sessions and surgery in Feb 2026. After surgery, all lymph nodes were clear.
Report timeline
| Date | Haemoglobin | White cells | CEA | Weight |
|---|
| 23 Nov 2025 | 8.6 | 2,800 | 20.9 | 44.45 kg |
| 7 Dec 2025 | 9.6 | 3,100 | – | 43.15 kg |
| 4 Jan 2026 | 11.0 | – | 2.35 | 42.35 kg |
| 15 Feb 2026 | 10.7 | 6,500 | – | 39.3 kg |
Still working on: Her weight fell from 44.45 to 39.3 kg during treatment, so nutrition is our main focus now.
Values copied from the patient's own reports. Shared with written consent. Results vary.
Patient story
Sheela S., 63
Breast cancer, stage 4, with spread to the spine · With us since Nov 2025
Weight (kg)
Nov 2025 → Apr 2026
PET-CT Nov 2025: no new disease
What changed
- Weight up from 54 to 58 kg
- Less lower-back pain
- Less numbness and burning in the soles
- Better appetite, digestion and energy
- Breathing easier
Alongside: She came to us after 18 cycles of chemotherapy and spine surgery, and continues follow-up with her oncologist.
Report timeline
| When | Finding |
|---|
| Nov 2025 (PET-CT, at start of our care) | No new disease; earlier skin nodule regressing |
| Nov 2025 | Weight 54 kg |
| Apr 2026 | Weight 58 kg |
Still working on: She continues regular scans with her oncology team.
Values copied from the patient's own reports. Shared with written consent. Results vary.
Patient story
Sunita P., 77
Breast cancer, operated in 2017 · on hormonal therapy · Dadar · With us: 1 year and 8 months
CA 15-3 (U/mL)
Sep 2024 → May 2026
CEA and CA-125 also within normal range
What changed
- Tumour markers within normal range on every report
- PET-CT (Sep 2024): no active disease
- Clinically stable, with no recurrence
Alongside: She continues the hormonal therapy prescribed by her oncologist.
Report timeline
| Marker | Sep 2024 | May 2026 |
|---|
| CA 15-3 | 13.7 | 14.0 |
| CEA | 1.9 | 1.83 |
| CA-125 | 14.5 | 9.44 |
Still working on: She has recently reported headaches and a small neck lump; an ultrasound suggests the lump is a harmless lipoma.
Values copied from the patient's own reports. Shared with written consent. Results vary.
